Nassim El Hajj
M.D.

Dr. Elhajj received his internal medicine degree from Staten Island University Hospital in Staten Island, New York, and completed his gastroenterology fellowship at SUNY Downstate Medical Center, Brooklyn, New York. Dr Elhajj joined our practice in 2008.

Videos
Postgraduate Education
2005 - 2008
Fellow, Gastroenterology and Hepatology
SUNY Downstate Medical Center
2004 - 2005
Chief Medical Resident
Staten Island University Hospital
2001 - 2004
Internal Medicine
Staten Island University Hospital
Publications

Pegylated interferon-induced immune-mediated hepatitis post-liver transplantation. Liver Transplantation Volume 12, Issue 5, Date: May 2006, Pages: 827-830

The development of DE NOVO autoimmune hepatitis (immune-mediated hepatitis) and its effect on outcome in patients with HCV post liver transplantation. Hepatology, Volume 44, Issue S1 (p 414A), Abstract # 606

Abstracts

The development of DE NOVO autoimmune hepatitis (immune-mediated hepatitis) and its effect on outcome in patients with HCV post liver transplantation. Poster presentation - AASLD meeting - Boston October 2006

The Risk of Acute Rejection in Patients Treated with Pegylated Interferon and Ribavirin for Recurrent Hepatitis C Post Liver Transplantation. Poster presentation - Digestive Disease Week - New Orleans May 2004

Improved Efficacy and Tolerability in Treating Post-Transplant HCV Utilizing an Escalating Regimen of Pegylated Interferon a-2a and Ribavirin with Hematopoietic Growth Factors: A Prospective Study. Oral presentation - Digestive Disease Week - New Orleans May 2004

Switching from Peg-Interferon a-2b to an escalating Peg-Interferon a-2a Regimen for recurrent Hepatitis C Post Liver Transplantation may Improve Virological Response and Tolerability. Poster presentation - Digestive Disease Week - New Orleans May 2004